Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00805870 · ClinicalTrials.gov registry record · Phase 2
The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers
A Phase 2 study, sponsored by Western Michigan University.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT00805870 is a Phase 2 study that has completed, run by Western Michigan University. The registered enrollment target is 20 participants.
The verdict
NCT00805870, a Phase 2 study, has completed, sponsored by Western Michigan University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of fish oil supplementation (Lovaza, GlaxoSmithKline) on muscle strength, muscle soreness and inflammation following exercise.
Interventions
- DRUG Lovaza (omega-3-acid ethyl esters)
- DRUG Wheat Germ Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00805870
The ClinicalTrials.gov registry entry for NCT00805870 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Western Michigan University, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lovaza (omega-3-acid ethyl esters) is the first listed.
NCT00805870 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00805870 about?
NCT00805870 is a clinical study titled "The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers". The purpose of this study is to determine the effects of fish oil supplementation (Lovaza, GlaxoSmithKline) on muscle strength, muscle soreness and inflammation following exercise.
What is the current status of trial NCT00805870?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2009-03. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00805870?
The interventions under investigation include: Lovaza (omega-3-acid ethyl esters) (DRUG), Wheat Germ Oil (DRUG).
Who is sponsoring clinical trial NCT00805870?
This trial is sponsored by Western Michigan University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.